Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia
Maureen Sampson, Clarence Ling, Qian Sun, et al.
JAMA Cardiology (2020) Vol. 5, Iss. 5, pp. 540-540
Open Access | Times Cited: 381

Showing 26-50 of 381 citing articles:

Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape—focus on hypertriglyceridaemia
Bilal Bashir, Jonathan Schofield, Paul Downie, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 8
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
Daniel Soffer, Nicholas Marston, Kevin C. Maki, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 5, pp. e647-e663
Closed Access | Times Cited: 8
Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association for Laboratory Medicine
Julia Kenkre, Tina Mazaheri, R. Dermot G. Neely, et al.
Annals of Clinical Biochemistry International Journal of Laboratory Medicine (2025)
Closed Access | Times Cited: 1
Beyond LDL cholesterol: remnant cholesterol is associated with cardiometabolic risk factors in children
Ana Torres‐Costoso, Vicente Martínez‐Vizcaíno, Andreia P. Oliveira, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Factors Associated with Advanced Liver Fibrosis in a Population with Type 2 Diabetes: A Multicentric Study in Mexico City.
Froylan David Martínez‐Sánchez, Maria Juliana Corredor-Nassar, Sandra Milena Feria-Agudelo, et al.
Journal of Clinical and Experimental Hepatology (2025) Vol. 15, Iss. 4, pp. 102536-102536
Open Access | Times Cited: 1
Measuring LDL-cholesterol: what is the best way to do it?
Anna Wolska, Alan T. Remaley
Current Opinion in Cardiology (2020) Vol. 35, Iss. 4, pp. 405-411
Open Access | Times Cited: 62
Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes
Fanny Jansson Sigfrids, Emma H. Dahlström, Carol Forsblom, et al.
Journal of Internal Medicine (2021) Vol. 290, Iss. 3, pp. 632-645
Open Access | Times Cited: 48
Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular Disease
Chris J. Packard
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 3, pp. 133-142
Open Access | Times Cited: 33
The Present and Future of Lipid Testing in Cardiovascular Risk Assessment
Nicole M.A. White-Al Habeeb, Victoria Higgins, Anna Wolska, et al.
Clinical Chemistry (2023) Vol. 69, Iss. 5, pp. 456-469
Closed Access | Times Cited: 19
Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients
Christeen Samuel, J.-S. Park, Aparna Sajja, et al.
Global Heart (2023) Vol. 18, Iss. 1, pp. 36-36
Open Access | Times Cited: 19
Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: The pooling project
Ernst J. Schaefer, Hiroaki Ikezaki, Margaret R. Diffenderfer, et al.
Atherosclerosis (2023) Vol. 367, pp. 15-23
Open Access | Times Cited: 18
Association of remnant cholesterol with frailty: findings from observational and Mendelian randomization analyses
Yuanlong Hu, Xiaojie Wang, Lin Lin, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans
Takahito Doi, Anne Langsted, Børge G. Nordestgaard
Journal of Atherosclerosis and Thrombosis (2023) Vol. 30, Iss. 11, pp. 1525-1546
Open Access | Times Cited: 16
Insulin resistance potentiates the effect of remnant cholesterol on cardiovascular mortality in individuals without diabetes
Arsenio Vargas‐Vázquez, Carlos A. Fermín‐Martínez, Neftalí Eduardo Antonio-Villa, et al.
Atherosclerosis (2024) Vol. 395, pp. 117508-117508
Open Access | Times Cited: 7
Electrochemical Biosensor for the detection of low density lipoprotein based on gold nanoparticles mediated bi-enzymes catalytic silver deposition reaction
Ruiyu Luo, J. Li, Guoying Huang, et al.
Microchemical Journal (2024) Vol. 199, pp. 109927-109927
Open Access | Times Cited: 6
Small dense low-density lipoprotein cholesterol and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis
Rishi Rikhi, Christopher L. Schaich, George W. Hafzalla, et al.
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 8, pp. 1048-1054
Open Access | Times Cited: 6
More accurate LDL-C calculation: Externally validated, guideline endorsed
Adam J. Brownstein, Seth S. Martin
Clinica Chimica Acta (2020) Vol. 506, pp. 149-153
Closed Access | Times Cited: 41
How low is safe? The frontier of very low (<30 mg/dL) LDL cholesterol
Angelos Karagiannis, Anurag Mehta, Devinder S. Dhindsa, et al.
European Heart Journal (2020) Vol. 42, Iss. 22, pp. 2154-2169
Open Access | Times Cited: 39
Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson’s, Martin’s and Friedewald’s equations
Arsenio Vargas‐Vázquez, Omar Yaxmehen Bello‐Chavolla, Neftali Eduardo Antonio‐Villa, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 35
Quantitative proteomic analyses during formation of chicken egg yolk
Yi Wang, Jinqiu Wang, Yaoqiang Shi, et al.
Food Chemistry (2021) Vol. 374, pp. 131828-131828
Closed Access | Times Cited: 34
LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equation 2 versus beta-quantification: pooled alirocumab trials
Henry N. Ginsberg, Robert S. Rosenson, G. Kees Hovingh, et al.
Journal of Lipid Research (2021) Vol. 63, Iss. 1, pp. 100148-100148
Open Access | Times Cited: 33
Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations
Gözde Ertürk Zararsız, Serkan Bolat, Ahu Cephe, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0263860-e0263860
Open Access | Times Cited: 26
Remnant cholesterol is associated with cardiovascular mortality
Kerui Zhang, Xiangyun Qi, Fuyu Zhu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 24
Lipid lowering with inclisiran: a real-world single-centre experience
Pritpal Padam, Lucy Barton, Stewart W. Wilson, et al.
Open Heart (2022) Vol. 9, Iss. 2, pp. e002184-e002184
Open Access | Times Cited: 24
Discordance Between Standard Equations for Determination of LDL Cholesterol in Patients With Atherosclerosis
Aparna Sajja, Hsin‐Fang Li, Kateri J. Spinelli, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 6, pp. 530-541
Open Access | Times Cited: 23

Scroll to top